investment

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.

A new report from the National Science Board identifies changes in the US’s global R&D investment and output, as well as in the country’s science and engineering workforce in recent years.

The midwestern state has quietly laid the groundwork for a biotech hub.

An investigation by Science reveals that charities’ investments support activities opposed to their own missions, such as human health and environmental protection.

New rankings highlight institutions that have produced large numbers of articles cited in others' patents.

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.

Federal officials are investigating whether the diagnostics company misled investors.

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.